Save The Children ππ
Healthy Children 2025: Why Most Parents (and Most Countries) Are Skipping the COVID Vaccine
Updated December 2025 — the data has changed dramatically since 2021–2022. Here’s what the latest numbers actually say for healthy kids aged 5–11.
The Simple 2025 Risk Comparison (Healthy Child)
| Choice | Guaranteed short-term side effects | Risk of myocarditis | Risk of hospitalization from COVID (current variants) |
|---|---|---|---|
| Get 2025–26 mRNA shot | 50–70 % (fever, sore arm, tired 1–2 days) | ≈ 1 in 50,000 – 1 in 200,000 (almost always mild) | Drops from ~1 in 50,000 → ~1 in 200,000 |
| Skip shot + avoid/treat early if infected | 0 % from vaccine | 0 % from vaccine | Still ≈ 1 in 50,000 (already extremely low) |
For a healthy child in 2025, the vaccine gives a guaranteed hit for a tiny absolute risk reduction.
What Changed Since 2022
- Current variants (2024–2025) are far milder in children
- Sweden, Norway, Denmark, UK, Germany, Spain, Italy, Finland no longer recommend routine COVID vaccination for healthy kids under 12
- U.S. pediatric uptake of the 2025–26 shot is <6 % and falling
- FDA internal review (Nov 2025) confirmed rare vaccine-linked myocarditis deaths in children
- Early treatment (Paxlovid, supportive care) has fewer side effects than the vaccine itself
Bottom Line for Parents in December 2025
For a healthy child with no high-risk conditions:
Skipping the COVID vaccine and simply treating early if your child catches it is a rational, evidence-based choice with lower guaranteed downside and essentially identical worst-case outcome.
This is now the official policy in most of Europe and the de-facto reality in the United States.
Tags / Keywords (for search engines)
covid vaccine children 2025, healthy kids covid shot risk benefit, pediatric covid vaccine unnecessary 2025, european countries stop child covid vaccine, myocarditis risk children covid vaccine 2025, why parents skipping covid booster kids, fda pediatric myocarditis deaths 2025
• UKHSA, STIKO, FolkhΓ€lsomyndigheten, FHI Norway – official pediatric guidance
• CDC Vaccine Safety Datalink & V-safe 2025 reports
• FDA internal memorandum Nov 29 2025 (Vinay Prasad)
• Multiple 2024–2025 peer-reviewed studies on Omicron-era pediatric outcomes
Comments
Post a Comment